For medical device startups, selecting the right contract development and manufacturing organization (CDMO) is one of the most important decisions you will make. The right partner can help accelerate development, reduce risk, and position your technology for successful commercialization. The wrong partner can create delays, increase costs, and introduce challenges that become difficult to overcome later in the product lifecycle.
Many startups evaluate CDMOs based solely on manufacturing capabilities. While manufacturing expertise is essential, the most valuable partners bring far more to the table. They contribute deep technical knowledge, help solve complex design challenges, and provide the infrastructure needed to support growth from early development through full scale production.
When evaluating a potential partner, there are three critical capabilities every startup should consider: materials science expertise, supply chain strength, and scalability.
A great CDMO understands more than how to manufacture a component. They understand the material itself and how its properties influence device performance, manufacturability, and cost.
This distinction is particularly important when working with highly engineered materials such as Nitinol, specialty polymers, or biomedical textiles. Early design decisions can significantly impact manufacturing complexity, product performance, and long-term commercial viability.
For startups operating with limited resources, partnering with a team that can provide material level guidance can prevent costly design iterations and shorten development timelines.
At Confluent, our engineers frequently work with customers to optimize designs before they reach production. In one recent Nitinol program, a customer approached us with component specifications that required extremely tight tolerances across multiple features. Following a detailed design review, our team identified opportunities to reengineer several features to improve manufacturability.
By tightening dimensional control where it was critical and relaxing precision requirements where it provided little functional benefit, we helped the customer achieve the same performance objectives while reducing manufacturing costs by approximately 50 to 70 percent.
This type of collaboration highlights the value of working with a partner that understands both the application and the underlying material science. The result is often a better product, lower costs, and a faster path to market.
For startups, time is often the most precious resource. Development delays can impact funding milestones, regulatory timelines, customer commitments, and commercialization plans.
That is why supply chain strength should be a key consideration when evaluating a CDMO partner.
A vertically integrated supply chain provides greater control over critical processes, improves communication between teams, and reduces the risk associated with managing multiple suppliers. It also enables faster troubleshooting when challenges arise.
At Confluent, we have strategically invested in vertically integrated capabilities that allow us to support customers throughout the development process. One example is our in-house extrusion expertise.
A customer developing a balloon catheter was experiencing inconsistent balloon expansion caused by poor tubing concentricity. Because extrusion was managed internally, our engineering team was able to quickly identify the root cause, refine the process, and deliver tubing with improved dimensional consistency.
The result was a more reliable component and improved balloon performance without the delays that often occur when coordinating corrective actions across multiple suppliers.
For startups working under aggressive timelines, this level of control can make a meaningful difference in both product performance and speed to market.
Many startups focus heavily on development capabilities without fully considering what happens after design validation and initial clinical success.
Investors, strategic partners, and potential acquirers want confidence that a product can scale successfully. A device that performs well in development must also be manufacturable at commercial volumes while maintaining quality and consistency.
Choosing a partner with both product development expertise and large-scale manufacturing capabilities helps eliminate the disruption that often occurs during technology transfer between suppliers.
Confluent's model is designed to support customers from concept through commercialization. Our Centers of Excellence across the United States provide specialized expertise in materials science, product development, and advanced manufacturing. As programs mature, customers can leverage our large-scale manufacturing operations in Costa Rica, where we support high volume production of complex medical device components and assemblies. Confluent's Costa Rica facility was specifically expanded to increase capacity for Nitinol processing and complex catheter manufacturing.
This integrated approach allows teams to maintain continuity throughout the product lifecycle while benefiting from the resources required to scale production efficiently.
For startups, that means fewer handoffs, reduced risk, and a clearer path from prototype to commercial success.
The best CDMO relationships are built on more than manufacturing capability. They are built on technical expertise, collaboration, and the ability to support growth over the long term.
When evaluating potential partners, look for organizations that can provide:
These capabilities not only support product development today but also help position your company for future growth.
At Confluent, we believe that successful partnerships are built by combining unrivaled materials science expertise, collaborative problem solving, and vertically integrated manufacturing solutions that help transform innovative concepts into life changing medical devices. From concept to commercialization, the right partner can make all the difference. Email sales@confluentmedical.com to get started today.